000 | 01341 a2200373 4500 | ||
---|---|---|---|
005 | 20250513112514.0 | ||
264 | 0 | _c19970331 | |
008 | 199703s 0 0 eng d | ||
022 | _a1350-0872 | ||
024 | 7 |
_a10.1099/00221287-143-2-519 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aSamuels, D Scott | |
245 | 0 | 0 |
_aOligonucleotide-mediated genetic transformation of Borrelia burgdorferi. _h[electronic resource] |
260 |
_bMicrobiology (Reading, England) _cFeb 1997 |
||
300 |
_a519-522 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 | _aAminocoumarins |
650 | 0 | 4 |
_aAnti-Bacterial Agents _xpharmacology |
650 | 0 | 4 |
_aBorrelia burgdorferi Group _xgenetics |
650 | 0 | 4 |
_aCoumarins _xpharmacology |
650 | 0 | 4 | _aDNA Gyrase |
650 | 0 | 4 |
_aDNA Topoisomerases, Type II _xgenetics |
650 | 0 | 4 | _aDNA, Single-Stranded |
650 | 0 | 4 | _aDrug Resistance, Microbial |
650 | 0 | 4 | _aElectroporation |
650 | 0 | 4 |
_aEnzyme Inhibitors _xpharmacology |
650 | 0 | 4 | _aMutagenesis, Site-Directed |
650 | 0 | 4 | _aOligonucleotides |
650 | 0 | 4 | _aTopoisomerase II Inhibitors |
650 | 0 | 4 | _aTransformation, Genetic |
700 | 1 | _aGaron, Claude F | |
773 | 0 |
_tMicrobiology (Reading, England) _gvol. 143 ( Pt 2) _gp. 519-522 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1099/00221287-143-2-519 _zAvailable from publisher's website |
999 |
_c9031706 _d9031706 |